Home: Maucher Jenkins

Intellectual Property


Patents | Trade Marks | Designs

News & Commentary

IP in the digital age: a tricky path ahead for pharma companies

Date: 20 September 2016

James Cross, Partner at Maucher Jenkins, has contributed to an article published by Life Sciences Intellectual Property Review concerning IP protection in the world of digital health and the need for pharmaceutical companies to adjust in the digital age.


You can read the full article from LSIPR by clicking here.